Acetazolamide (All indications)

Study	Reference
Battino (Acetazolamide) (Epilepsy), 2024	Battino Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol 2024; 81:481-489 Tomson T Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
Christensen (Acetazolamide) (All indications) (Controls exposed to LTG), 2024	Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849
Christensen (Acetazolamide) (All indications) (Controls unexposed, general population), 2024	Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849
Samrén (Acetazolamide), 1999	Samrén Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999; 46:739-46
Vajda (Acetazolamide) (Controls exposed to Lamotrigine, sick), 2019	Jazayeri Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications. Seizure 2018; 56:111-114 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11
Vajda (Acetazolamide) (Controls unexposed, sick), 2019	Jazayeri Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications. Seizure 2018; 56:111-114 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11